{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:45:29Z","timestamp":1792626329514,"version":"4.5.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190272","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T19:11:24Z","timestamp":1515697884000},"page":"e0190272","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-662X","authenticated-orcid":true,"given":"Guido J. H.","family":"Bastiaens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred B.","family":"Tiono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Okebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmi E.","family":"Pett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam A.","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronner P.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Affara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonse","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith C.","family":"Bougouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume S.","family":"Sanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"N\u00e9bi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjerstin H. W.","family":"Lanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Niemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodiomon B.","family":"Sirima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"d\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teun","family":"Bousema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Drakeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"ref1","article-title":"World Malaria Report 2016","year":"2016"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"e1000396","DOI":"10.1371\/journal.pmed.1000396","article-title":"A research agenda for malaria eradication: diagnoses and diagnostics","volume":"8","year":"2011","journal-title":"PLoS Med"},{"issue":"3","key":"ref3","first-page":"CD007483","article-title":"Artemisinin-based combination therapy for treating uncomplicated malaria","author":"D Sinclair","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2875-7-125","article-title":"Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials","volume":"7","author":"LC Okell","year":"2008","journal-title":"Malar J."},{"issue":"47","key":"ref5","doi-asserted-by":"crossref","first-page":"E1214","DOI":"10.1073\/pnas.1112037108","article-title":"Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue","volume":"108","author":"SH Adjalley","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/CMR.00051-10","article-title":"Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination","volume":"24","author":"T Bousema","year":"2011","journal-title":"Clinical microbiology reviews"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/319689","article-title":"Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae","volume":"183","author":"G Targett","year":"2001","journal-title":"J Infect Dis"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/infdis\/jit077","article-title":"Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial","volume":"207","author":"P Sawa","year":"2013","journal-title":"J Infect Dis"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(12)70198-6","article-title":"Primaquine to prevent transmission of falciparum malaria","volume":"13","author":"NJ White","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/424663","article-title":"Primaquine therapy for malaria","volume":"39","author":"JK Baird","year":"2004","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1473-3099(13)70268-8","article-title":"Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial","volume":"14","author":"AC Eziefula","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12916-016-0581-y","article-title":"Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"BP Goncalves","year":"2016","journal-title":"BMC Med"},{"key":"ref13","article-title":"Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial","author":"A Dicko","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13063-015-0597-1","article-title":"The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial","volume":"16","author":"J Okebe","year":"2015","journal-title":"Trials"},{"key":"ref15","article-title":"Guidelines for the treatment of malaria","year":"2015"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.01135-09","article-title":"In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals","volume":"54","author":"SA Shekalaghe","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","first-page":"621","article-title":"Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report","volume":"22","author":"AS Alving","year":"1960","journal-title":"Bulletin of the World Health Organization"},{"issue":"5","key":"ref18","first-page":"349","article-title":"Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency","volume":"95","author":"PA Reeve","year":"1992","journal-title":"The Journal of tropical medicine and hygiene"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1128\/AAC.05566-11","article-title":"Tolerability and safety of primaquine in Papua New Guinean children 1 to 10 years of age","volume":"56","author":"I Betuela","year":"2012","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/AAC.01879-12","article-title":"Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia","volume":"57","author":"I Sutanto","year":"2013","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12916-015-0535-9","article-title":"Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia","volume":"13","author":"EJ Nelwan","year":"2015","journal-title":"BMC Med"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"e1023","DOI":"10.1371\/journal.pone.0001023","article-title":"Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate","volume":"2","author":"S Shekalaghe","year":"2007","journal-title":"PLoS One"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/AAC.02889-14","article-title":"Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine","volume":"58","author":"AC Eziefula","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"e0151898","DOI":"10.1371\/journal.pone.0151898","article-title":"Single low dose primaquine (0.25mg\/kg) does not cause clinically significant haemolysis in G6PD deficient subjects","volume":"11","author":"G Bancone","year":"2016","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12936-016-1341-3","article-title":"Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania","volume":"15","author":"R Mwaiswelo","year":"2016","journal-title":"Malar J"},{"key":"ref26","article-title":"Safety and efficacy of adding a single low dose of primaquine to the treatment of adult patients with Plasmodium falciparum malaria in Senegal, to reduce gametocyte carriage: a randomized controlled trial","author":"RC Tine","year":"2017","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1475-2875-11-360","article-title":"Rationale for short course primaquine in Africa to interrupt malaria transmission","volume":"11","author":"AC Eziefula","year":"2012","journal-title":"Malar J"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.1979.tb03774.x","article-title":"International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency","volume":"43","author":"E Beutler","year":"1979","journal-title":"Br J Haematol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s12936-016-1584-z","article-title":"Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity","volume":"15","author":"H Pett","year":"2016","journal-title":"Malar J"},{"issue":"14","key":"ref30","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1301936","article-title":"Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria","volume":"369","author":"JW Bennett","year":"2013","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1475-2875-12-212","article-title":"The metabolism of primaquine to its active metabolite is dependent on CYP 2D6","volume":"12","author":"BS Pybus","year":"2013","journal-title":"Malar J"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.00015-15","article-title":"Differential CYP 2D6 metabolism alters primaquine pharmacokinetics","volume":"59","author":"BM Potter","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/FPC.0b013e3283546d3c","article-title":"CYP2D6 update: revised nomenclature for CYP2D7\/2D6 hybrid genes","volume":"22","author":"SC Sim","year":"2012","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.clpt.6100406","article-title":"The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype","volume":"83","author":"A Gaedigk","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1389200215666140202215316","article-title":"Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization","volume":"15","author":"JK Hicks","year":"2014","journal-title":"Curr Drug Metab"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12936-016-1145-5","article-title":"Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial","volume":"15","author":"PL St Jean","year":"2016","journal-title":"Malar J"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"e0123549","DOI":"10.1371\/journal.pone.0123549","article-title":"Malarial anaemia and anaemia severity in apparently healthy primary school children in urban and rural settings in the Mount Cameroon area: cross sectional survey","volume":"10","author":"IU Sumbele","year":"2015","journal-title":"PloS one"},{"issue":"19","key":"ref38","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.1980.03300450023014","article-title":"The predictive value of serum haptoglobin in hemolytic disease","volume":"243","author":"A Marchand","year":"1980","journal-title":"JAMA"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0272-2712(18)31007-2","article-title":"Application of the predictive value model in the analysis of test effectiveness","volume":"2","author":"RS Galen","year":"1982","journal-title":"Clin Lab Med"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V84.11.3613.bloodjournal84113613","article-title":"G6PD deficiency","volume":"84","author":"E Beutler","year":"1994","journal-title":"Blood"},{"issue":"9606","key":"ref41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"371","author":"MD Cappellini","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"ref42","first-page":"30","article-title":"The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity","volume":"45","author":"RJ Dern","year":"1955","journal-title":"The Journal of laboratory and clinical medicine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-13-418","article-title":"Primaquine: the risks and the benefits","volume":"13","author":"EA Ashley","year":"2014","journal-title":"Malar J"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4269\/ajtmh.2001.65.614","article-title":"Factors contributing to anemia after uncomplicated falciparum malaria","volume":"65","author":"RN Price","year":"2001","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"3","key":"ref45","first-page":"439","article-title":"The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis","volume":"44","author":"E Beutler","year":"1954","journal-title":"The Journal of laboratory and clinical medicine"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4269\/ajtmh.12-0682","article-title":"An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines","volume":"88","author":"P Zhang","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4269\/ajtmh.2007.77.779","article-title":"Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development","volume":"77","author":"E Beutler","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1475-2875-12-391","article-title":"G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests","volume":"12","author":"GJ Domingo","year":"2013","journal-title":"Malar J"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ejhg.2009.8","article-title":"Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. European journal of human genetics","volume":"17","author":"TG Clark","year":"2009","journal-title":"EJHG"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pt.2016.09.004","article-title":"Mathematical modelling to guide drug development for malaria elimination","volume":"33","author":"HC Slater","year":"2017","journal-title":"Trends Parasitol"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"e1003434","DOI":"10.1371\/journal.pcbi.1003434","article-title":"Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination","volume":"10","author":"GL Johnston","year":"2014","journal-title":"PLoS Comput Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T14:07:02Z","timestamp":1603634822000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190272"}},"subtitle":[],"editor":[{"given":"Jacobus P.","family":"van Wouwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190272","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]}}}